Branched-chain α-keto acid dehydrogenase (BCKD) is a mitochondrial enzyme complex that oxidatively decarboxylates branched-chain amino acid breakdown products, linking leucine, isoleucine, and valine catabolism to energy metabolism.
Branched-chain α-keto acid dehydrogenase, usually shortened to BCKD or BCKDH, is the enzyme complex that finishes the breakdown of branched-chain amino acids in Biological Chemistry I. After leucine, isoleucine, or valine is first transaminated into a branched-chain α-keto acid, BCKD removes a carboxyl group and helps convert that carbon skeleton into a molecule that can keep getting metabolized.
The reaction is an oxidative decarboxylation, which means the substrate loses CO2 while electrons are transferred during the process. That is why BCKD sits in the same general family as pyruvate dehydrogenase and α-ketoglutarate dehydrogenase. These complexes are built around the same chemistry, even though they act on different substrates.
BCKD is not a single protein doing one tiny step. It is a multi-enzyme complex with coordinated parts that pass the intermediate from one active site to the next. In class, you may see the same cofactors recur here: thiamine pyrophosphate (TPP), lipoate, coenzyme A, FAD, and NAD+. Each cofactor has a job, from forming the first carbon-carbon bond rearrangement to carrying electrons away at the end.
The products are acyl-CoA derivatives, which means the amino acid carbon skeleton has been converted into a form that can enter central metabolism. For valine and isoleucine, the pathway feeds into citric acid cycle intermediates indirectly. Leucine is fully ketogenic, so its breakdown supports acetyl-CoA and acetoacetate production instead of net glucose formation.
BCKD is tightly regulated because amino acid catabolism should ramp up or slow down depending on energy state and nutrient availability. When the complex is less active, branched-chain amino acids and their α-keto acids build up. When it works properly, it gives the cell a way to pull carbon from dietary protein into broader metabolic pathways.
BCKD is one of the cleanest examples of how Biological Chemistry I connects amino acid metabolism to central carbon metabolism. If you can track what happens to leucine, isoleucine, and valine after transamination, you can see how protein-derived carbon gets folded into the same energy network that runs the citric acid cycle.
This term also shows up whenever your course talks about multi-enzyme complexes and cofactor chemistry. BCKD is a good reminder that enzymes do not always work as isolated proteins. They can be organized into assembly lines, with TPP, lipoate, FAD, NAD+, and CoA each contributing to a specific chemical step.
It matters clinically too. A deficiency in the complex leads to maple syrup urine disease, where branched-chain amino acids and their byproducts accumulate. That gives you a direct link between pathway defects and metabolic symptoms, which is the kind of connection biochemistry classes love to test with case questions.
Finally, BCKD helps you reason through fasting, high-protein intake, and tissue energy needs. If the body needs to use amino acids for fuel, this is one of the control points that decides how far those carbon skeletons can go.
Keep studying Biological Chemistry I Unit 8
Visual cheatsheet
view galleryBranched-Chain Amino Acids
BCKD acts on the breakdown products of leucine, isoleucine, and valine. You usually meet the amino acids first, then their α-keto acids, then this dehydrogenase complex. If a problem asks where these amino acids go after transamination, BCKD is the next major step.
Citric Acid Cycle
BCKD does not run the citric acid cycle itself, but it funnels amino acid carbon into metabolites that connect to it. That is why the enzyme belongs in the section on pathway integration. When BCKD is working well, protein carbon can support energy production through the broader metabolic network.
Acyl-CoA
The point of the BCKD reaction is to turn a branched-chain α-keto acid into an acyl-CoA derivative. That product form is metabolically useful because it can be further oxidized or converted into other central intermediates. If you can identify the acyl-CoA product, you are usually one step ahead on pathway questions.
glutamate dehydrogenase
Glutamate dehydrogenase and BCKD both sit in amino acid catabolism, but they handle different parts of the nitrogen-carbon split. Glutamate dehydrogenase helps release amino groups as ammonia or ammonium, while BCKD works on the carbon skeleton after transamination. Seeing both together helps you separate nitrogen disposal from fuel production.
A quiz or problem set may give you a branched-chain amino acid pathway and ask you to name the enzyme that oxidatively decarboxylates the α-keto acid. You might also be asked to predict what accumulates in a deficiency, or to trace how leucine, isoleucine, and valine feed into energy metabolism. In a case question, look for elevated branched-chain amino acids plus a block in the complex and connect that to maple syrup urine disease. If the prompt asks about cofactors, match BCKD with TPP, lipoate, FAD, NAD+, and CoA. When a diagram shows amino acid carbon entering central metabolism, this is the step to label.
Branched-chain α-keto acid dehydrogenase is the enzyme complex that continues the catabolism of leucine, isoleucine, and valine after transamination.
Its reaction is an oxidative decarboxylation, so it removes CO2 and moves the carbon skeleton toward central metabolism.
The complex uses the same core cofactors as other dehydrogenase assemblies, including TPP, lipoate, FAD, NAD+, and CoA.
A loss of BCKD activity causes branched-chain amino acids and their α-keto acids to build up, which is the biochemical basis of maple syrup urine disease.
In Biological Chemistry I, BCKD is a classic example of how amino acid catabolism connects to the citric acid cycle and cellular energy flow.
It is the mitochondrial enzyme complex that breaks down branched-chain amino acid α-keto acids after the first transamination step. The reaction converts those carbon skeletons into acyl-CoA derivatives that can keep feeding metabolism.
BCKD helps oxidatively decarboxylate their breakdown products, which moves the carbon skeletons further into catabolism. Leucine, isoleucine, and valine do not enter this step directly as amino acids, but as their corresponding α-keto acids.
Transaminase does the first step, moving the amino group off the amino acid and forming the α-keto acid. BCKD acts after that and handles the oxidative decarboxylation step. That separation is a common source of confusion on pathway questions.
The branched-chain amino acids and their α-keto acid byproducts accumulate, which can damage the nervous system. The classic disorder linked to this defect is maple syrup urine disease, named for the sweet odor of the urine.